• Kolesnikova, Viktoriia
• Ondrackova, Lucie
• Lischkova, Lucie
• Rossnerova, Andrea
• Klusackova, Pavlina
• Zdimal, Vladimir
• Vlckova, Stepanka
• Fenclova, Zdenka
• Ondracek, Jakub
• Schwarz, Jaroslav
• Komarc, Martin
• Kostejn, Martin
• Navratil, Tomas
• Dvorackova, Stepanka
• Pelclova, Daniela

Abstract

<jats:p>Human data concerning exposure to nanoparticles are very limited, and biomarkers for monitoring exposure are urgently needed. In a follow-up of a 2016 study in a nanocomposites plant, in which only exhaled breath condensate (EBC) was examined, eight markers of oxidative stress were analyzed in three bodily fluids, i.e., EBC, plasma and urine, in both pre-shift and post-shift samples in 2017 and 2018. Aerosol exposures were monitored. Mass concentration in 2017 was 0.351 mg/m3 during machining, and 0.179 and 0.217 mg/m3 during machining and welding, respectively, in 2018. In number concentrations, nanoparticles formed 96%, 90% and 59%, respectively. In both years, pre-shift elevations of 50.0% in EBC, 37.5% in plasma and 6.25% in urine biomarkers were observed. Post-shift elevation reached 62.5% in EBC, 68.8% in plasma and 18.8% in urine samples. The same trend was observed in all biological fluids. Individual factors were responsible for the elevation of control subjects’ afternoon vs. morning markers in 2018; all were significantly lower compared to those of workers. Malondialdehyde levels were always acutely shifted, and 8-hydroxy-2-deoxyguanosine levels best showed chronic exposure effect. EBC and plasma analysis appear to be the ideal fluids for bio-monitoring of oxidative stress arising from engineered nanomaterials. Potential late effects need to be targeted and prevented, as there is a similarity of EBC findings in patients with silicosis and asbestosis.</jats:p>

Topics

• nanoparticle
• nanocomposite
• impedance spectroscopy
• electron beam curing